HEPION PHARMACEUTICALS, INC. Pre-Tax Income
HEPION PHARMACEUTICALS, INC. (HEPA) reported Pre-Tax Income of -$8.28 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Income Statement
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2026-03-12
- HEPION PHARMACEUTICALS, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-12-31 was -$656.88K.
- HEPION PHARMACEUTICALS, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-09-30 was -$472.51K.
- HEPION PHARMACEUTICALS, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-06-30 was -$1.04M.
- HEPION PHARMACEUTICALS, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-03-31 was -$6.11M.
- HEPION PHARMACEUTICALS, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2025 was -$8.28M.
- HEPION PHARMACEUTICALS, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2024 was -$16.16M.
- HEPION PHARMACEUTICALS, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2023 was -$49.34M.
- HEPION PHARMACEUTICALS, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2022 was -$45.08M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | -$656.88K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$1.13M derived: sum of 2 quarters · filed 2026-03-12 | -$2.17M derived: sum of 3 quarters · filed 2026-03-12 | -$8.28M 10-K · filed 2026-03-12 | |||
| 2025-09-30 | -$472.51K 10-Q · filed 2025-11-12 | -$1.52M derived: sum of 2 quarters · filed 2025-11-12 | -$7.62M 10-Q · filed 2025-11-12 | -$9.17M derived: sum of 4 quarters · filed 2026-03-12 | |||
| 2025-06-30 | -$1.04M 10-Q · filed 2025-08-14 | -$7.15M 10-Q · filed 2025-08-14 | -$8.70M derived: sum of 3 quarters · filed 2026-03-12 | -$13.56M derived: sum of 4 quarters · filed 2026-03-12 | |||
| 2025-03-31 | -$6.11M 10-Q · filed 2025-05-19 | -$7.65M derived: sum of 2 quarters · filed 2026-03-12 | -$12.52M derived: sum of 3 quarters · filed 2026-03-12 | -$16.44M derived: sum of 4 quarters · filed 2026-03-12 | |||
| 2024-12-31 | -$1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$6.41M derived: sum of 2 quarters · filed 2026-03-12 | -$10.34M derived: sum of 3 quarters · filed 2026-03-12 | -$16.16M 10-K · filed 2026-03-12 | |||
| 2024-09-30 | -$4.87M 10-Q · filed 2025-11-12 | -$8.79M derived: sum of 2 quarters · filed 2025-11-12 | -$14.61M 10-Q · filed 2025-11-12 | -$26.08M derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | -$3.93M 10-Q · filed 2025-08-14 | -$9.75M 10-Q · filed 2025-08-14 | -$21.22M derived: sum of 3 quarters · filed 2025-08-14 | -$31.74M derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | -$5.82M 10-Q · filed 2025-05-19 | -$17.29M derived: sum of 2 quarters · filed 2025-05-19 | -$27.82M derived: sum of 3 quarters · filed 2025-05-19 | -$41.90M derived: sum of 4 quarters · filed 2025-05-19 | |||
| 2023-12-31 | -$11.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-08 | -$22.00M derived: sum of 2 quarters · filed 2025-04-08 | -$36.08M derived: sum of 3 quarters · filed 2025-04-08 | -$49.34M 10-K · filed 2025-04-08 | |||
| 2023-09-30 | -$10.53M 10-Q · filed 2024-11-14 | -$24.61M derived: sum of 2 quarters · filed 2024-11-14 | -$37.87M 10-Q · filed 2024-11-14 | -$47.56M derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | -$14.08M 10-Q · filed 2024-08-13 | -$27.34M 10-Q · filed 2024-08-13 | -$37.03M derived: sum of 3 quarters · filed 2024-08-13 | -$45.58M derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | -$13.26M 10-Q · filed 2024-05-21 | -$22.96M derived: sum of 2 quarters · filed 2024-05-21 | -$31.50M derived: sum of 3 quarters · filed 2024-05-21 | -$51.41M derived: sum of 4 quarters · filed 2024-05-21 | |||
| 2022-12-31 | -$9.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | -$18.24M derived: sum of 2 quarters · filed 2024-04-16 | -$38.15M derived: sum of 3 quarters · filed 2024-04-16 | -$45.08M 10-K · filed 2024-04-16 | |||
| 2022-09-30 | -$8.55M 10-Q · filed 2023-11-20 | -$28.46M derived: sum of 2 quarters · filed 2023-11-20 | -$35.39M 10-Q · filed 2023-11-20 | -$45.11M derived: sum of 4 quarters · filed 2023-11-20 | |||
| 2022-06-30 | -$19.91M 10-Q · filed 2023-08-14 | -$26.84M 10-Q · filed 2023-08-14 | -$36.56M derived: sum of 3 quarters · filed 2023-08-14 | -$45.83M derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | -$6.93M 10-Q · filed 2023-05-12 | -$16.65M derived: sum of 2 quarters · filed 2023-05-12 | -$25.92M derived: sum of 3 quarters · filed 2023-05-12 | -$33.59M derived: sum of 4 quarters · filed 2023-05-12 | |||
| 2021-12-31 | -$9.72M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-10 | -$18.99M derived: sum of 2 quarters · filed 2023-04-10 | -$26.66M derived: sum of 3 quarters · filed 2023-04-10 | -$32.72M 10-K · filed 2023-04-10 | |||
| 2021-09-30 | -$9.27M 10-Q · filed 2022-11-14 | -$9.27M 10-Q · filed 2021-11-15 | -$16.94M derived: sum of 2 quarters · filed 2022-11-14 | -$23.00M 10-Q · filed 2022-11-14 | -$22.99M 10-Q · filed 2021-11-15 | -$27.96M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$7.67M 10-Q · filed 2022-08-15 | -$7.67M 10-Q · filed 2021-08-16 | -$13.73M 10-Q · filed 2022-08-15 | -$13.72M 10-Q · filed 2021-08-16 | -$18.69M derived: sum of 3 quarters · filed 2022-08-15 | -$24.98M derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | -$6.06M 10-Q · filed 2022-05-16 | -$6.06M 10-Q · filed 2021-05-14 | -$11.02M derived: sum of 2 quarters · filed 2022-05-16 | -$17.32M derived: sum of 3 quarters · filed 2022-05-16 | -$22.16M derived: sum of 4 quarters · filed 2022-05-16 | ||
| 2020-12-31 | -$4.96M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | -$11.25M derived: sum of 2 quarters · filed 2022-04-08 | -$16.10M derived: sum of 3 quarters · filed 2022-04-08 | -$20.32M 10-K · filed 2022-04-08 | |||
| 2020-09-30 | -$6.29M 10-Q · filed 2021-11-15 | -$11.14M derived: sum of 2 quarters · filed 2021-11-15 | -$15.36M 10-Q · filed 2021-11-15 | -$17.53M derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | -$4.84M 10-Q · filed 2021-08-16 | -$9.07M 10-Q · filed 2021-08-16 | -$11.23M derived: sum of 3 quarters · filed 2021-08-16 | -$13.05M derived: sum of 4 quarters · filed 2021-08-16 | |||
| 2020-03-31 | -$4.23M 10-Q · filed 2021-05-14 | -$6.39M derived: sum of 2 quarters · filed 2021-05-14 | -$8.21M derived: sum of 3 quarters · filed 2021-05-14 | -$10.19M derived: sum of 4 quarters · filed 2021-05-14 | |||
| 2019-12-31 | -$2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$3.98M derived: sum of 2 quarters · filed 2021-03-31 | -$5.96M derived: sum of 3 quarters · filed 2021-03-31 | -$7.95M 10-K · filed 2021-03-31 | |||
| 2019-09-30 | -$1.82M 10-Q · filed 2020-11-16 | -$3.80M derived: sum of 2 quarters · filed 2020-11-16 | -$5.79M 10-Q · filed 2020-11-16 | -$8.36M derived: sum of 4 quarters · filed 2020-11-16 | |||
| 2019-06-30 | -$1.98M 10-Q · filed 2020-08-12 | -$3.97M 10-Q · filed 2020-08-12 | -$6.54M derived: sum of 3 quarters · filed 2020-08-12 | -$6.70M derived: sum of 4 quarters · filed 2020-08-12 | |||
| 2019-03-31 | -$1.98M 10-Q · filed 2020-06-29 | -$4.56M derived: sum of 2 quarters · filed 2020-06-29 | -$4.71M derived: sum of 3 quarters · filed 2020-06-29 | -$8.74M derived: sum of 4 quarters · filed 2020-06-29 | |||
| 2018-12-31 | -$2.57M derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-14 | -$2.73M derived: sum of 2 quarters · filed 2020-05-14 | -$6.76M derived: sum of 3 quarters · filed 2020-05-14 | -$9.99M 10-K · filed 2020-05-14 | |||
| 2018-09-30 | -$157.06K 10-Q · filed 2019-11-14 | -$4.19M derived: sum of 2 quarters · filed 2019-11-14 | -$7.41M 10-Q · filed 2019-11-14 | -$11.10M derived: sum of 4 quarters · filed 2019-11-14 | |||
| 2018-06-30 | -$4.03M 10-Q · filed 2019-08-14 | -$7.26M 10-Q · filed 2019-08-14 | -$10.94M derived: sum of 3 quarters · filed 2019-08-14 | -$16.71M derived: sum of 4 quarters · filed 2019-08-14 | |||
| 2018-03-31 | -$3.23M 10-Q · filed 2019-05-15 | -$6.91M derived: sum of 2 quarters · filed 2019-05-15 | -$12.69M derived: sum of 3 quarters · filed 2019-05-15 | -$10.64M derived: sum of 4 quarters · filed 2019-05-15 | |||
| 2017-12-31 | -$3.68M derived: 10-K 6 month − 10-Q 3 month · filed 2019-03-14 | -$9.46M 10-K · filed 2019-03-14 | -$7.41M derived: sum of 3 quarters · filed 2019-03-14 | -$15.03M 10-K · filed 2019-03-14 | |||
| 2017-09-30 | -$5.77M 10-Q · filed 2018-11-14 | -$3.72M derived: sum of 2 quarters · filed 2018-11-14 | -$11.34M 10-Q · filed 2018-11-14 | -$17.76M derived: sum of 4 quarters · filed 2018-11-14 | |||
| 2017-06-30 | $2.05M 10-Q · filed 2018-08-14 | -$5.57M 10-Q · filed 2018-08-14 | -$11.98M derived: sum of 3 quarters · filed 2018-08-14 | -$16.80M 10-K · filed 2019-03-14 | |||
| 2017-03-31 | -$7.62M 10-Q · filed 2018-05-15 | -$14.03M derived: sum of 2 quarters · filed 2018-05-15 | -$18.85M 10-Q · filed 2017-04-12 | ||||
| 2016-12-31 | -$6.41M 10-Q · filed 2017-02-14 | -$11.23M 10-KT · filed 2018-03-26 | |||||
| 2016-06-30 | -$5.21M derived: 10-KT 12 month − 10-Q 9 month · filed 2018-03-26 | -$9.12M derived: sum of 2 quarters · filed 2018-03-26 | -$12.15M derived: sum of 3 quarters · filed 2018-03-26 | -$17.00M 10-KT · filed 2018-03-26 | |||
| 2016-03-31 | -$3.92M 10-Q · filed 2017-04-12 | -$6.95M derived: sum of 2 quarters · filed 2017-04-12 | -$11.79M 10-Q · filed 2017-04-12 | ||||
| 2015-12-31 | -$3.03M 10-Q · filed 2017-02-14 | -$7.87M 10-Q · filed 2017-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |